- Home
- BMRN vs DOCU Comparison
BMRN vs DOCU Comparison
Compare BMRN & DOCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | DOCU |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 9.6B |
| IPO Year | 1999 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BMRN | DOCU |
|---|---|---|
| Price | $54.55 | $42.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 17 |
| Target Price | ★ $88.22 | $66.60 |
| AVG Volume (30 Days) | 1.7M | ★ 4.6M |
| Earning Date | 04-30-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.80 | 1.48 |
| Revenue | $1,313,646,000.00 | ★ $3,219,500,000.00 |
| Revenue This Year | $15.02 | $10.58 |
| Revenue Next Year | $12.23 | $7.42 |
| P/E Ratio | $31.27 | ★ $30.78 |
| Revenue Growth | ★ 17.62 | 8.16 |
| 52 Week Low | $50.76 | $40.16 |
| 52 Week High | $66.28 | $94.67 |
Technical Indicators
Market Signals| Indicator | BMRN | DOCU |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 34.03 |
| Support Level | $53.71 | $40.85 |
| Resistance Level | $56.21 | $51.40 |
| Average True Range (ATR) | 1.33 | 2.31 |
| MACD | 0.13 | -0.27 |
| Stochastic Oscillator | 26.33 | 6.84 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.